REGN stock stories: Regeneron Pharmaceuticals moves, results and patterns
Daily stories about Regeneron Pharmaceuticals (REGN) stock, found automatically and backed by evidence. Every claim is labelled observed, calculated or possible contributor.
Regeneron Pharmaceuticals (REGN) financials and filings →
REGN beat EPS estimates by 21.8%2026-10-30 · REGN
REGN +13.4%: one of its biggest daily moves this year2026-10-30 · REGN
Statistics only, not investment advice.